Table 2. Percentages of subjects diagnosed with non‐alcoholic steatohepatitis and scores for steatosis, inflammation, and ballooning, total non‐alcoholic fatty liver disease activity scores and staging of non‐alcoholic steatohepatitis.
| NGT | IFG | DM | P‐value | |
|---|---|---|---|---|
| Subjects diagnosed with NASH based on total NAS (%) | 21.6 | 65.2** | 41.7 | 0.0002 |
| Subjects diagnosed with NASH based on the Matteoni classification (%) | 40.9 | 65.2 | 58.3 | 0.0503 |
| Steatosis | 1.65 ± 0.63 | 2.00 ± 0.74* | 1.83 ± 0.66 | 0.0493 |
| Inflammation | 0.80 ± 0.79 | 1.17 ± 0.83 | 0.92 ± 0.73 | 0.1181 |
| Ballooning | 0.84 ± 0.74 | 1.22 ± 0.60* | 1.17 ± 0.81* | 0.0226 |
| Total NAS | 3.28 ± 1.44 | 4.39 ± 1.60** | 3.92 ± 1.63* | 0.0035 |
| Staging of NASH | 0.61 ± 0.90 | 1.09 ± 1.04* | 0.97 ± 1.03 | 0.0419 |
Values are means ± SD.
*P < 0.05; **P < 0.01 vs normal glucose tolerance.
DM, diabetes; IFG, impaired fasting glucose; NAS, non‐alcoholic fatty liver disease activity scores; NASH, non‐alcoholic steatohepatitis.